The Association Of Angiotensin Converting Enzyme Inhibitors (acei)/angiotensin Ii Receptor Antagonists (arb) And Pneumonia Requiring Admission In Patients With Chronic Obstructive Pulmonary Disease (COPD)

被引:0
|
作者
Kim, J. [1 ]
Yim, H. [2 ]
Park, S. [2 ]
Heo, E. [2 ]
Chung, H. [2 ]
Kim, D. [2 ]
机构
[1] Seoul Natl Univ Hosp, Seoul, South Korea
[2] SMG SNU Boramae Med Ctr, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1124
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Non allergic rhinitis associated with angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists
    Montoro de Francisco, A. M.
    Garcia Luque, A.
    Burgos Pimentel, A. M.
    Fonseca Avendano, J. A.
    De Vicente Jiménez, T.
    Puerro Vicente, M.
    Mateos Galvan, J. M.
    ALLERGY, 2013, 68 : 381 - 382
  • [32] Preface - Additional potential applications of angiotensin converting enzyme inhibitors and of angiotensin II receptor antagonists
    Molteni, A
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (09)
  • [33] Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    Liu, Chia-Lin
    Shau, Wen-Yi
    Chang, Chia-Hsuin
    Wu, Chi-Shin
    Lai, Mei-Shu
    JOURNAL OF EPIDEMIOLOGY, 2013, 23 (05) : 344 - 350
  • [34] Combined angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB) therapy is safe and effective in kidney transplant patients
    Reilly, James B.
    Goral, Simin
    Bloom, Roy D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 533 - 533
  • [35] Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease
    ElAbd, Rawan
    AlTarrah, Dana
    AlYouha, Sarah
    Bastaki, Hamad
    Almazeedi, Sulaiman
    Al-Haddad, Mohannad
    Jamal, Mohammad
    AlSabah, Salman
    FRONTIERS IN MEDICINE, 2021, 8
  • [36] Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers (ACEI/ARB) are Associated with Improved Limb Salvage after Infrapopliteal Interventions for Critical Limb Ischemia
    Khan, Sikandar Z.
    Montross, Brittany
    Rivero, Mariel
    Cherr, Gregory S.
    Harris, Linda M.
    Dryjski, Maciej L.
    Dosluoglu, Hasan H.
    ANNALS OF VASCULAR SURGERY, 2020, 63 : 275 - 286
  • [37] Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease
    Hopkinson, NS
    Nickol, AH
    Payne, J
    Hawe, E
    Man, WDC
    Moxham, J
    Montgomery, H
    Polkey, MI
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (04) : 395 - 399
  • [38] Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
    Qiao, Yao
    Shin, Jung-Im
    Sang, Yingying
    Inker, Lesley
    Secora, Alex
    Coresh, Josef
    Alexander, G. Caleb
    Jackson, John
    Chang, Alex
    Grams, Morgan
    CIRCULATION, 2019, 139
  • [39] Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
    Qiao, Yao
    Shin, Jung-Im
    Sang, Yingying
    Inker, Lesley A.
    Secora, Alex
    Luo, Shengyuan
    Coresh, Josef
    Alexander, G. Caleb
    Jackson, John W.
    Chang, Alex R.
    Grams, Morgan E.
    MAYO CLINIC PROCEEDINGS, 2019, 94 (11) : 2220 - 2229
  • [40] Could angiotensin II type I receptor antagonists (ARAT1) better prevent stroke than angiotensin II converting enzyme inhibitors (ACEI)?
    Fournier, A
    Achard, JM
    Mazouz, H
    Pruna, A
    Hottelart, C
    Rosa, A
    Fernandez, L
    Andrejak, M
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1999, 92 (08): : 997 - 1000